IFPMA 2014 interview series ‘What’s an innovation ecosystem from an industry perspective’
In this interview IFPMA President, Dr John Lechleiter, talks about vital components of the innovation ecosystem that need to be in place to bring value to patients. Dr Lechleiter discusses the need for an enabling environment that allows for greater investments in R&D through adequate incentives and efficient allocation of human and financial resources. He also underscores the need for efficient regulatory systems that are predictable, consistent, transparent, and scientifically rigorous to ensure quality, safety and efficacy of the products delivered.
About IFPMA
IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere.
ifpma.org
To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.
Related news and resources
#AlwaysInnovating: Pharmaceutical Industry Facts & Figures
This compendium of facts and figures aims to provide a snapshot of the contribution of the pharmaceutical industry. Pharmaceutical companies are at the forefront of developing medicines and vaccines that change how we fight and prevent disease and help solve today’s biggest health challenges. In addition to their contribution to healthier societies, pharmaceutical companies also...
Read more
WIPO Standing Committee on Patents: Statement on Technology Transfer
On 16 October 2024 in Geneva, IFPMA delivered a statement at the 36th meeting of WIPO’s Standing Committee on Patents:, on technology transfer.
Read moreWIPO Standing Committee on Patents: Statement on Patents and Health
On 16 October 2024 in Geneva, IFPMA delivered a statement at the 36th meeting of WIPO’s Standing Committee on Patents: Patents and Health.
Read more